This Plain Language Summary of Publication article (PLSP) from Future Oncology discusses the genetic and molecular changes in the tumors of participants with BRAF V600E–mutant metastatic colorectal cancer who were treated with encorafenib plus cetuximab, with or without binimetinib, in the BEACON study.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial’ and was published in Nature Medicine.

Visit Nature using the link to read the original article.